Concepts (147)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Granulosa Cells | 7 | 2022 | 42 | 2.950 |
Why?
|
Repressor Proteins | 8 | 2016 | 249 | 2.660 |
Why?
|
Signal Transduction | 8 | 2023 | 1908 | 1.640 |
Why?
|
Curcumin | 3 | 2023 | 74 | 1.600 |
Why?
|
Endometriosis | 3 | 2023 | 73 | 1.530 |
Why?
|
Neuregulin-1 | 2 | 2022 | 23 | 1.440 |
Why?
|
Apoptosis | 7 | 2017 | 1398 | 1.260 |
Why?
|
Gonadotropins | 5 | 2022 | 27 | 1.190 |
Why?
|
MicroRNAs | 3 | 2023 | 426 | 1.150 |
Why?
|
Ovarian Follicle | 3 | 2017 | 35 | 1.080 |
Why?
|
Cytokines | 3 | 2023 | 602 | 0.940 |
Why?
|
Sexual Maturation | 1 | 2022 | 23 | 0.830 |
Why?
|
Mammary Glands, Animal | 1 | 2022 | 26 | 0.830 |
Why?
|
Endometrium | 2 | 2023 | 60 | 0.820 |
Why?
|
Cell Differentiation | 5 | 2016 | 587 | 0.760 |
Why?
|
Toll-Like Receptors | 1 | 2021 | 51 | 0.750 |
Why?
|
Stromal Cells | 2 | 2018 | 49 | 0.680 |
Why?
|
Cell Survival | 3 | 2017 | 864 | 0.650 |
Why?
|
bcl-X Protein | 2 | 2017 | 27 | 0.620 |
Why?
|
Caspase 3 | 5 | 2022 | 207 | 0.610 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2018 | 121 | 0.600 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 2 | 2017 | 152 | 0.580 |
Why?
|
Animals | 16 | 2022 | 15081 | 0.550 |
Why?
|
Follicle Stimulating Hormone | 1 | 2016 | 43 | 0.540 |
Why?
|
Rats | 7 | 2022 | 3483 | 0.490 |
Why?
|
Female | 15 | 2023 | 20969 | 0.470 |
Why?
|
Staurosporine | 2 | 2017 | 38 | 0.440 |
Why?
|
Mitochondria | 5 | 2016 | 487 | 0.420 |
Why?
|
MAP Kinase Signaling System | 1 | 2013 | 169 | 0.410 |
Why?
|
Tumor Necrosis Factor-alpha | 3 | 2023 | 356 | 0.390 |
Why?
|
Trichomonas Vaginitis | 1 | 2011 | 5 | 0.390 |
Why?
|
Trichomonas vaginalis | 1 | 2011 | 8 | 0.390 |
Why?
|
Ceramides | 1 | 2011 | 42 | 0.390 |
Why?
|
Caspases | 2 | 2008 | 147 | 0.380 |
Why?
|
NF-kappa B | 3 | 2023 | 339 | 0.330 |
Why?
|
Proto-Oncogene Proteins c-akt | 2 | 2023 | 269 | 0.330 |
Why?
|
Pineal Gland | 1 | 2008 | 31 | 0.320 |
Why?
|
Pituitary Gland | 2 | 2006 | 63 | 0.320 |
Why?
|
Rats, Sprague-Dawley | 4 | 2017 | 1618 | 0.310 |
Why?
|
Melatonin | 1 | 2008 | 82 | 0.310 |
Why?
|
Cytochromes c | 3 | 2013 | 53 | 0.290 |
Why?
|
Humans | 15 | 2023 | 37093 | 0.270 |
Why?
|
Ovary | 2 | 2017 | 108 | 0.250 |
Why?
|
Neuropeptide Y | 1 | 2004 | 24 | 0.250 |
Why?
|
Enzyme Inhibitors | 1 | 2006 | 433 | 0.240 |
Why?
|
RNA, Messenger | 2 | 2006 | 1207 | 0.230 |
Why?
|
Leptin | 1 | 2004 | 118 | 0.220 |
Why?
|
Follicular Atresia | 1 | 2022 | 6 | 0.220 |
Why?
|
Morphogenesis | 1 | 2022 | 50 | 0.210 |
Why?
|
Lactation | 1 | 2022 | 40 | 0.210 |
Why?
|
Chemokines | 1 | 2022 | 97 | 0.200 |
Why?
|
Uterine Neoplasms | 1 | 2022 | 39 | 0.200 |
Why?
|
Mammals | 1 | 2022 | 105 | 0.200 |
Why?
|
Leiomyoma | 1 | 2022 | 30 | 0.200 |
Why?
|
Phosphorylation | 2 | 2016 | 928 | 0.190 |
Why?
|
Gene Expression Regulation | 2 | 2006 | 1015 | 0.180 |
Why?
|
Immunity, Innate | 1 | 2021 | 149 | 0.180 |
Why?
|
Cells, Cultured | 3 | 2011 | 1518 | 0.170 |
Why?
|
Adenoviridae | 2 | 2011 | 62 | 0.170 |
Why?
|
Follicular Fluid | 1 | 2017 | 4 | 0.150 |
Why?
|
Theca Cells | 1 | 2017 | 4 | 0.150 |
Why?
|
Receptor, erbB-3 | 1 | 2017 | 12 | 0.150 |
Why?
|
Taxoids | 1 | 2017 | 37 | 0.140 |
Why?
|
Pregnancy | 1 | 2022 | 1549 | 0.140 |
Why?
|
Protein Kinase C | 1 | 2017 | 120 | 0.140 |
Why?
|
Phosphoproteins | 1 | 2017 | 163 | 0.140 |
Why?
|
Receptor, erbB-2 | 1 | 2017 | 133 | 0.140 |
Why?
|
Thyrotropin, beta Subunit | 2 | 2006 | 2 | 0.140 |
Why?
|
Steroids | 1 | 2016 | 43 | 0.130 |
Why?
|
Gene Expression | 2 | 2011 | 674 | 0.130 |
Why?
|
Gene Knockdown Techniques | 1 | 2016 | 173 | 0.130 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2011 | 1039 | 0.130 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2017 | 182 | 0.130 |
Why?
|
Testosterone | 1 | 2016 | 193 | 0.130 |
Why?
|
Neovascularization, Pathologic | 1 | 2016 | 127 | 0.130 |
Why?
|
Exosomes | 1 | 2016 | 101 | 0.120 |
Why?
|
Infertility, Female | 1 | 2014 | 24 | 0.120 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2016 | 286 | 0.120 |
Why?
|
Inflammation | 1 | 2018 | 618 | 0.120 |
Why?
|
Subcellular Fractions | 1 | 2012 | 77 | 0.100 |
Why?
|
Microscopy, Phase-Contrast | 1 | 2011 | 10 | 0.100 |
Why?
|
Culture Media, Serum-Free | 1 | 2011 | 45 | 0.100 |
Why?
|
Antitrichomonal Agents | 1 | 2011 | 2 | 0.100 |
Why?
|
Trichomonas Infections | 1 | 2011 | 3 | 0.100 |
Why?
|
Nitroimidazoles | 1 | 2011 | 10 | 0.100 |
Why?
|
Androgens | 1 | 2012 | 89 | 0.100 |
Why?
|
Cell Culture Techniques | 1 | 2011 | 142 | 0.090 |
Why?
|
Colitis | 1 | 2010 | 65 | 0.090 |
Why?
|
RNA, Small Interfering | 1 | 2011 | 409 | 0.080 |
Why?
|
Blotting, Western | 1 | 2011 | 859 | 0.080 |
Why?
|
Thyrotropin-Releasing Hormone | 2 | 2006 | 13 | 0.080 |
Why?
|
Cell Physiological Phenomena | 1 | 2008 | 9 | 0.080 |
Why?
|
Drug Delivery Systems | 1 | 2010 | 202 | 0.080 |
Why?
|
Protein Structure, Quaternary | 1 | 2008 | 64 | 0.080 |
Why?
|
Phylogeny | 2 | 2008 | 644 | 0.080 |
Why?
|
Prostatic Neoplasms | 1 | 2017 | 935 | 0.080 |
Why?
|
Enzyme Activation | 1 | 2008 | 444 | 0.070 |
Why?
|
Cattle | 1 | 2008 | 477 | 0.070 |
Why?
|
Ducks | 1 | 2006 | 8 | 0.070 |
Why?
|
Phosphatidylserines | 1 | 2006 | 21 | 0.070 |
Why?
|
Molecular Structure | 1 | 2008 | 492 | 0.070 |
Why?
|
Intracellular Membranes | 1 | 2006 | 38 | 0.070 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2006 | 623 | 0.070 |
Why?
|
Time Factors | 1 | 2011 | 1742 | 0.070 |
Why?
|
Blood Proteins | 1 | 2006 | 66 | 0.070 |
Why?
|
Membrane Potential, Mitochondrial | 1 | 2006 | 84 | 0.070 |
Why?
|
DNA, Complementary | 1 | 2006 | 191 | 0.070 |
Why?
|
Nanoparticles | 1 | 2010 | 318 | 0.070 |
Why?
|
Cell Death | 1 | 2006 | 267 | 0.060 |
Why?
|
Transfection | 1 | 2006 | 523 | 0.060 |
Why?
|
Glycoprotein Hormones, alpha Subunit | 1 | 2004 | 2 | 0.060 |
Why?
|
Male | 5 | 2017 | 20025 | 0.060 |
Why?
|
Rats, Wistar | 1 | 2004 | 233 | 0.060 |
Why?
|
DNA Primers | 1 | 2004 | 286 | 0.060 |
Why?
|
Neoplasms | 1 | 2014 | 1103 | 0.060 |
Why?
|
Analysis of Variance | 1 | 2004 | 550 | 0.060 |
Why?
|
Myometrium | 1 | 2022 | 13 | 0.050 |
Why?
|
Organoids | 1 | 2022 | 22 | 0.050 |
Why?
|
Stem Cells | 1 | 2022 | 141 | 0.050 |
Why?
|
Estrogens | 1 | 2022 | 202 | 0.050 |
Why?
|
Autocrine Communication | 1 | 2016 | 12 | 0.030 |
Why?
|
Culture Media | 1 | 2016 | 90 | 0.030 |
Why?
|
Genital Neoplasms, Female | 1 | 2014 | 11 | 0.030 |
Why?
|
Cell Proliferation | 1 | 2017 | 1198 | 0.020 |
Why?
|
Caco-2 Cells | 1 | 2010 | 52 | 0.020 |
Why?
|
Mice, Mutant Strains | 1 | 2010 | 80 | 0.020 |
Why?
|
Acute Disease | 1 | 2010 | 147 | 0.020 |
Why?
|
Cell Line, Tumor | 1 | 2017 | 2231 | 0.020 |
Why?
|
Green Fluorescent Proteins | 1 | 2010 | 208 | 0.020 |
Why?
|
Intestinal Mucosa | 1 | 2010 | 122 | 0.020 |
Why?
|
Recombinant Fusion Proteins | 1 | 2010 | 295 | 0.020 |
Why?
|
Adult | 2 | 2016 | 11712 | 0.020 |
Why?
|
Computer Systems | 1 | 2006 | 19 | 0.020 |
Why?
|
Thyroxine | 1 | 2006 | 19 | 0.020 |
Why?
|
Triiodothyronine | 1 | 2006 | 32 | 0.020 |
Why?
|
Blotting, Northern | 1 | 2006 | 150 | 0.020 |
Why?
|
Glucocorticoids | 1 | 2006 | 86 | 0.020 |
Why?
|
Tissue Distribution | 1 | 2006 | 207 | 0.020 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2006 | 269 | 0.020 |
Why?
|
Cloning, Molecular | 1 | 2006 | 325 | 0.020 |
Why?
|
Mice, Inbred C57BL | 1 | 2010 | 1609 | 0.020 |
Why?
|
Disease Models, Animal | 1 | 2010 | 1371 | 0.020 |
Why?
|
Sequence Analysis, DNA | 1 | 2006 | 474 | 0.020 |
Why?
|
Base Sequence | 1 | 2006 | 997 | 0.020 |
Why?
|
Amino Acid Sequence | 1 | 2006 | 1180 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2006 | 1568 | 0.010 |
Why?
|
Mice | 1 | 2010 | 5913 | 0.010 |
Why?
|